Quantitative sensory testing defines the trajectory of sensory neuropathy after severe COVID-19.
Ponirakis G, Odriozola A, Ortega L, Martinez L, Odriozola S, Torrens A, Coroleu D, Martínez S, Sanz X, Ponce M, Meije Y, Clemente M, Duarte A, Odriozola MB, Malik RA.
Ponirakis G, et al. Among authors: odriozola mb.
Diabetes Res Clin Pract. 2024 Jan;207:111029. doi: 10.1016/j.diabres.2023.111029. Epub 2023 Nov 24.
Diabetes Res Clin Pract. 2024.
PMID: 38007044